Better Therapeutics, Inc. specializes in creating innovative software-driven prescription digital therapeutics (PDTs) platforms, primarily for the U.S. market. These advanced therapies are developed to manage and treat various cardiometabolic ailments, such as diabetes and heart disease. Their flagship investigational product, BT-001, is a PDT platform that employs digitally delivered Nutritional Cognitive Behavioral Therapy (NCBT) to address type 2 diabetes. The company's development pipeline further includes BT-002, a PDT designed to assist patients with hypertension in controlling their blood pressure, and BT-003, another PDT focused on helping individuals with hyperlipidemia optimize their cholesterol levels. Established in 2015, Better Therapeutics, Inc. operates from its headquarters in San Francisco, California.
The current price of BTTX is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Better Therapeutics stock price performance more closely on the chart.
What is Better Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Better Therapeutics stocks are traded under the ticker BTTX.
What is Better Therapeutics market cap?▼
Today Better Therapeutics has the market capitalization of 4,740.3
What is Better Therapeutics revenue for the last year?▼
Better Therapeutics revenue for the last year amounts to 0 USD.
What is Better Therapeutics net income for the last year?▼
BTTX net income for the last year is -79.52M USD.
How many employees does Better Therapeutics have?▼
As of June 09, 2026, the company has 54 employees.
In which sector is Better Therapeutics located?▼
Better Therapeutics operates in the Health & Wellness sector.
When did Better Therapeutics complete a stock split?▼
Better Therapeutics has not had any recent stock splits.
Where is Better Therapeutics headquartered?▼
Better Therapeutics is headquartered in San Francisco, United States.